HK inno.N

About:

Develops and sells immune anticancer drugs, blood disease drugs, kidney disease drugs, and other products.

Website: http://www.inno-n.com/eng/

Top Investors: STIC Investment

Description:

CJ HealthCare Corp. develops pharmaceutical vaccines.

Total Funding Amount:

80.1B KRW

Estimated Revenue Range:

$500M to $1B

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2014-01-01

Founders:

Number of Employees:

1001-5000

Last Funding Date:

2018-01-01

IPO Status:

Public

Industries: